216 related articles for article (PubMed ID: 21477705)
1. [Safety of daptomycin in patients with renal impairment].
Azanza JR; Quetglas EG
Med Clin (Barc); 2010 Dec; 135 Suppl 3():55-9. PubMed ID: 21477705
[TBL] [Abstract][Full Text] [Related]
2. [Daptomycin in the treatment of Gram-positive infections in patients with chronic renal failure].
Sarriá Cepeda C
Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():38-42. PubMed ID: 22541974
[TBL] [Abstract][Full Text] [Related]
3. [Clinical experience with daptomycin use in Spain. Global findings from EU-CORE database].
Almirante B
Med Clin (Barc); 2010 Dec; 135 Suppl 3():23-8. PubMed ID: 21477701
[TBL] [Abstract][Full Text] [Related]
4. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
[TBL] [Abstract][Full Text] [Related]
5. [Daptomycin for the treatment of Gram-positive microorganisms in the critically-ill patient].
Alvarez-Lerma F; Gracia-Arnillas MP
Med Clin (Barc); 2010 Dec; 135 Suppl 3():29-35. PubMed ID: 21477702
[TBL] [Abstract][Full Text] [Related]
6. [Daptomycin in diabetic patients].
Montejo M
Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():54-8. PubMed ID: 22541977
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Effectiveness and Safety of High-Dose Daptomycin: Results from Patients Included in the European Cubicin(®) Outcomes Registry and Experience.
Seaton RA; Menichetti F; Dalekos G; Beiras-Fernandez A; Nacinovich F; Pathan R; Hamed K
Adv Ther; 2015 Dec; 32(12):1192-205. PubMed ID: 26610384
[TBL] [Abstract][Full Text] [Related]
8. [The second life of daptomycin: analysis of a successful come-back].
Decousser JW; Doucet Populaire F
Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
[No Abstract] [Full Text] [Related]
9. Daptomycin: the role of high-dose and combination therapy for Gram-positive infections.
Gould IM; Miró JM; Rybak MJ
Int J Antimicrob Agents; 2013 Sep; 42(3):202-10. PubMed ID: 23845504
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
Kullar R; McClellan I; Geriak M; Sakoulas G
Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
[TBL] [Abstract][Full Text] [Related]
11. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
12. [Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections].
Mathiesen L; Midtvedt T; Solberg CO
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2383-4. PubMed ID: 16998552
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenous daptomycin in Japanese pediatric patients: Pharmacokinetic comparisons supporting dosing recommendations in Japanese pediatric patients.
Ishii M; Orito Y; Shiomi M; Wrishko RE; Yoshitsugu H
J Infect Chemother; 2023 Jun; 29(6):592-598. PubMed ID: 36868408
[TBL] [Abstract][Full Text] [Related]
14. Safety of daptomycin in patients receiving hemodialysis.
Mueller BA; Crompton JA; Donovan BJ; Yankalev S; Lamp KC
Pharmacotherapy; 2011 Jul; 31(7):665-72. PubMed ID: 21923453
[TBL] [Abstract][Full Text] [Related]
15. Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.
Gonzalez-Ruiz A; Gargalianos-Kakolyris P; Timerman A; Sarma J; José González Ramallo V; Bouylout K; Trostmann U; Pathan R; Hamed K
Adv Ther; 2015 Jun; 32(6):496-509. PubMed ID: 26108157
[TBL] [Abstract][Full Text] [Related]
16. Management of cSSTIs: the role of daptomycin.
Garau J
Curr Med Res Opin; 2006 Nov; 22(11):2079-87. PubMed ID: 17076967
[TBL] [Abstract][Full Text] [Related]
17. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
18. [Challenges in the antimicrobial treatment of infective endocarditis. Role of daptomycin].
Almirante B; Miró JM
Enferm Infecc Microbiol Clin; 2012 Feb; 30 Suppl 1():26-32. PubMed ID: 22541972
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin.
Enoch DA; Bygott JM; Daly ML; Karas JA
J Infect; 2007 Sep; 55(3):205-13. PubMed ID: 17629567
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.
Hair PI; Keam SJ
Drugs; 2007; 67(10):1483-512. PubMed ID: 17600394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
